PROPRANOLOL ON ANTIPYRINE CLEARANCE/Greenblatt,

نویسندگان

  • Franke
  • Huffman
چکیده

tions on short-term therapy (two weeks) for penicillin-sensitive streptococcal endocarditis. Med Clin North Am, July 1958, pp 1 101-1 140 8. Kaye D: Changes in the spectrum, diagnosis and management of bacterial and fungal endocarditis. Med Clin North Am 57: 941, 1973 9. Tan JS, Kaplan S, Terhune CA Jr, Hamburger M: Successful two-week treatment schedule for penicillin-susceptible streptococcus viridans endocarditis. Lancet 2: 1340, 1971 10. Hoeprich PD: Infectious Diseases: A Guide to the Understanding and Management of Infectious Processes. Hagerstown, Maryland, Harper & Row, Publishers, 1972, p 1956 ll. Tompsett R, Hurst ML: Bacterial endocarditis: Selected aspects of treatment. Trans Am Clin Climat Assoc 83: 95, 1972 12. Hunter TH: The treatment of some bacterial infections of the heart and pericardium. Bull NY Acad Med 28: 213, 1952 13. Friedberg CK: Diseases of the Heart, ed 3. Philadelphia, WB Saunders Company, 1966, p 242 14. Washington JA II: Laboratory Procedures in Clinical Microbiology. Boston, Little, Brown & Company, 1974 15. Duperval R, Bill NJ, Geraci JE, Washington JA II: Bactericidal activity of combinations of penicillin or clindamycin with gentamicin or streptomycin against species of viridans streptococci. Antimicrob Agents Chemother 8: 673, 1975 16. Wolfe JC, Johnson WD Jr: Penicillin-sensitive streptococcal endocarditis: in-vitro and clinical observations on penicillin-streptomycin therapy. Ann Intern Med 81: 178, 1974 17. Durack DT, Petersdorf RG: Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest 52: 592, 1973 18. Hunter TH, Paterson PY: Bacterial endocarditis. DM, November 1956, pp 1-48 19. Tompsett R, Robbins WC, Berntsen C Jr: Short-term penicillin and dihydrostreptomycin therapy of streptococcal endocarditis: results of the treatment of thirty-five patients. Am J Med 24: 57, 1958 20. Hamburger M, Stein L: Streptococcus viridans subacute bacterial endocarditis: two week treatment schedule with penicillin. JAMA 149: 542, 1952 21. Cates JE, Christie V: Subacute bacterial endocarditis: a review of 442 patients treated in 14 centres appointed by the Penicillin Trials Committee of the Medical Research Council. Q J Med 20: 93, 1951 22. Christie RV: Subacute bacterial endocarditis. Br Med J 2: 438, 1953 23. Karchmer AW, Moellering RC Jr, Maki D, Swartz MN: Single antibiotic therapy of streptococcal endocarditis (SE). Program and Abstracts of the Seventeenth Interscience Conference on Antimicrobial Agents and Chemotherapy, 1977, no. 238 24. Hoppes WL, Smith JW, Lerner PI, White A: Treatment of penicillinsensitive streptococcal endocarditis (PSSE). Program and Abstracts of the Seventeenth Interscience Conference on Antimicrobial Agents and Chemotherapy, 1977, no. 239 25. Pelletier LL Jr, Petersdorf RG: Chemotherapy of experimental streptococcal endocarditis. V. Effect of duration of infection and retained intracardiac catheter on response to treatment. J Lab Clin Med 87: 692, 1976 26. Sande MA, Irvin RG: Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis 129: 572, 1974 27. Durack DT, Pelletier LL, Petersdorf RG: Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. J Clin Invest 53: 829, 1974 28. Hook EW, Guerrant RL: Therapy of infective endocarditis. In Infective Endocarditis, edited by Kaye D. Baltimore, University Park Press, 1976, p 169; 172; 173 29. Griffin FM Jr, Jones G, Cobbs CG: Aortic insufficiency in bacterial endocarditis. Ann Intern Med 76: 23, 1972 30. Wilson WR, Jaumin PM, Danielson GK, Washington JA II, Giuliani ER, Geraci JE: Cardiac valve replacement in patients with congestive heart failure (CHF) caused by infective endocarditis (IE). Program and Abstracts of the Fifteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, 1975, no. 195

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Impairment of antipyrine clearance in humans by propranolol.

The effect of propranolol on antipyrine clearance in humans was evaluated in six healthy volunteers who received single 1.4 to 1.5 g doses of intravenous antipyrine on two occasions. The first (control) antipyrine trial was without concurrent drug administration; the second trial was done during treatment with therapeutic doses of propranolol (40 mg every 4 to 6 hours). Antipyrine elimination h...

متن کامل

Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis.

We determined the clearance of antipyrine before, and during, the administration of propranolol in eight male patients with alcoholic cirrhosis and a recent episode of gastrointestinal bleeding. The clearance of antipyrine in these patients was markedly reduced as compared with that in eight male, age-matched control subjects but was not further decreased after 1 month of propranolol administra...

متن کامل

Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.

The effects of phenobarbital treatment for 12 days on the regional distribution of blood flow and on the disposition of two model drugs, antipyrine and d-propranolol, have been determined in six unanesthetized rhesus monkeys. Phenobarbital significantly increased total hepatic blood flow from 179+/-15 to 239+/-27 ml/min. Liver weight was increased to a similar degree (34%) in phenobarbital-trea...

متن کامل

Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.

Beta-adrenergic receptor blockers decrease intravenous anesthetic dose requirements. The present study determined the effect of propranolol on indocyanine green and antipyrine disposition from the moment of rapid intravenous injection. Anti-pyrine is a physiological marker that distributes to a volume as large as total body water in a blood flow-dependent manner and is a pharmacokinetic surroga...

متن کامل

Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.

This study investigated the relative contribution of ion-trapping, microsomal binding, and distribution of unbound drug as determinants in the hepatic retention of basic drugs in the isolated perfused rat liver. The ionophore monensin was used to abolish the vesicular proton gradient and thus allow an estimation of ion-trapping by acidic hepatic vesicles of cationic drugs. In vitro microsomal s...

متن کامل

Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.

Fourteen healthy volunteers received a single i.v. dose of antipyrine (1.2 g) on two occasions, once before and once during cimetidine treatment (300 mg every 6 hr). In a similar manner, 8 subjects received diazepam (10 mg), 11 subjects received acetaminophen (650 mg) and 8 subjects received lorazepam (2 mg), all by the i.v. route, once before and once during cimetidine coadministration. Pharma...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005